Shree Ganesh Biotech India Share Price

CMP as on20-May-22 15:49

₹ 3.06
-0.15 -4.67%

Open

₹ 3.34

Turnover (lac)

₹ 24

Prev. Close

₹ 3.21

Day's Vol (shares)

₹ 28,91,025

Day's Range

₹ 3.00
₹ 3.35

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 29-Apr-2022 - -
Apropos the captioned subject please be informed that the Board of Directors have in the allotment meeting held on April 29, 2022 alloted 19,93,12,000 bonus equity shares to the shareholders entitled for these shares subsequently increasing the paid up and issued capital of the Company from Rs. 19,93,12,000/-(divided into 19,93,12,000 equity shares of the face value of Rs.1/-each) to Rs. 39,86,24,000/-(divided into 39,86,24,000 equity shares of the face value of Rs.1/-each). We further wish to inform that the said 19,93,12,000 bonus shares will be credited to the account of respective shareholders on or before May 6,2022. This is for your information and records pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking you.
Board Meeting - 03-Feb-2022 - -
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2022 inter alia to consider and approve the declaration of issue of bonus shares to the equity shareholders of the company. Kindly take the above intimation into your records. Thanking you. This is to inform that the Board of Directors at its meeting held on Monday, 07th March, 2022 have approved and recommended the issuance of fully paid-up Bonus Shares in the ratio of 1:1 (i.e. 1 (one) fully paid up equity share for every 1 (one) fully paid up equity share held, subject to the shareholders approval through Postal Ballot. Please take the above intimation in your records. Thanking You. (As Per BSE Announcement Dated on 07.03.2022)
Board Meeting - 25-Jan-2022 - -
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday February 1 2022 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2021 also transact other business activities. Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith un-audited financial result for quarter ended 31st December 2021. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement dated on 01.02.2022)
Board Meeting - 10-Dec-2021 - -
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/12/2021 ,inter alia, to consider and approve 1. To approve Sub-Division of Face Value of Equity Shares of Rs. 10/- into Rs. 1/- per Equity Share. 2. To change the Clause V - Authorised Capital of Memorandum of Articles according. 3. To approve notice of General Meeting to seek approval for the above-mentioned items as recommended by Board. 4. Any other business as Board deem fit to discuss, with the permission of the Chairman. Please take the above intimation in your records. Thanking You Pursuant to Second proviso to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 20th December 2021 at the Registered Office of the Company and recommended the proposal of sub- division of Companys shares from face Value of Rs 10 each per share to face Value of Rs.1 each per share. Please, take above on your records and oblige us. Pursuant to Second proviso to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 20th December 2021 at the Registered Office of the Company and transacted the following major businesses: 1 Recommended the proposal of sub- division of Companys 1 (one) equity shares of face value of Rs. 10/- each into 10(ten) equity shares of face value of Rs 1/-each subject to approval by shareholders. Record date for Split/Sub-division of Nominal Value will be intimated in due course subject to compliance of necessary laws. 2 Recommended alteration of Capital Clause (Clause V) in the Memorandum of Association of the Company, subject to the approval by shareholders. 3 Considered & approved the draft notice of Postal Ballot. Please, take above on your records and oblige us. (As Per BSE Announcement Dated on 20.12.2021)
Board Meeting - 28-Oct-2021 - -
Quarterly Results Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, be and is hereby given that the meeting of the Board of Directors of the Company will be held on Saturday , November 13, 2021, inter alia, to consider the Un-Audited financial results of the company for quarter and half year ended on September 30, 2021 and also transact other business activities. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Saturday November 13, 2021 at the Registered Office of the Company and transacted the following major businesses: 1. Approval of Un-audited financial results for quarter and half year ended as on 30th September, 2021. 2. The Registered office of the company is shifted to Cubicle No:126,3/2 ,75C,PARK STREET,3RD FLOOR ,KAMDHENU BUILDING ,KOLKATA-700016 w.e.f 13.11.2021 Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement dated on 13.11.2021)
Board Meeting - 04-Aug-2021 - -
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 11th August 2021 inter alia, to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2021. Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial results for quarter ended 30th June, 2021. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated on 11.08.2021)
Board Meeting - 17-Jun-2021 - -
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Friday 25th June, 2021 to approve and take on record the Audited Financial Results of the Company for the quarter and year ended on 31st March 2021 and to transact the other business as the board deem fits. This is to inform you that Outcome of the Board Meeting of the Company held on Friday 25th June 2021 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2021. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2021. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2021 with unmodified opinion. Request you to kindly take on record the same. Thanking You. (As Per BSE Announcement dated on 25.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity